|
As ADA 2020 wraps up...
|
3
|
Resverlogix Corp.
|
Jun 16, 2020 04:31PM
|
|
Re: Still not finding on ClinicalTrials gov - Dexamethasone is SoC as well
|
3
|
Resverlogix Corp.
|
Apr 22, 2021 12:21PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
3
|
Resverlogix Corp.
|
Jan 13, 2021 04:50PM
|
|
Re: Would a functional cure for T1D affect RVX and T2D?
|
3
|
Resverlogix Corp.
|
Jan 15, 2021 05:26PM
|
|
New NIH Study on Alzheimer's Disease
|
3
|
Resverlogix Corp.
|
Apr 14, 2020 01:52PM
|
|
Exercise of options Norma Biln
|
3
|
Resverlogix Corp.
|
Jul 28, 2020 11:36PM
|
|
Re: Some more reading material
|
3
|
Resverlogix Corp.
|
May 01, 2020 08:12PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property - question
|
3
|
Resverlogix Corp.
|
Nov 02, 2020 12:49PM
|
|
BETonRENAL
|
3
|
Resverlogix Corp.
|
Nov 16, 2020 09:50PM
|
|
Re: COVID trial now in CTD
|
3
|
Resverlogix Corp.
|
May 15, 2021 12:23PM
|
|
Baricitinib restrains the immune dysregulation in COVID 19 patients
|
3
|
Resverlogix Corp.
|
Jun 30, 2020 06:59PM
|
|
New study in the Lancet regarding COVID 19 and blood clotting
|
3
|
Resverlogix Corp.
|
Jun 30, 2020 07:09PM
|
|
Re: BETonMACE paper just published
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 01:13PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
3
|
Resverlogix Corp.
|
Jun 07, 2020 11:12AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
3
|
Resverlogix Corp.
|
Jun 07, 2020 11:34AM
|
|
PartnerS
|
3
|
Resverlogix Corp.
|
Jun 10, 2020 11:12AM
|
|
March Presentation
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 01:02PM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk
|
3
|
Resverlogix Corp.
|
Jun 03, 2020 09:59PM
|
|
Re: Proactive Article - new presentation on website
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2020 08:37AM
|
|
Warrants
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 20, 2020 12:37PM
|
